Characteristic | Intervention group (n=73) | Control group (n=69) |

Mean age (SD) (years) | 66.6 (11.5) | 65.9 (10.8) |

Male | n=33 (45.2%) | n=44 (63.8%) |

Histology of lesion | ||

BCC | n=55 (75.3%) | n=52 (75.4%) |

SCC | n=7 (9.6%) | n=8 (11.6%) |

IEC | n=10 (13.7%) | n=9 (13.0%) |

Dysplastic naevus | n=1 (1.4%) | n=0 |

Body site of lesion | ||

Nose | n=55 (75.3%) | n=45 (65.2%) |

Ear | n=18 (24.7%) | n=24 (34.8%) |

Smoker | n=4 (5.5%) | n=6 (8.7%) |

Diabetes mellitus | n=8 (11.0%) | n=8 (11.6%) |

Anticoagulant medication | n=19 (26.0%) | n=17 (24.6%) |

Immunosuppressive medication | n=1 (1.4%) | n=1 (1.4%) |

Median time to surgery (IQR) (min) | 50 (45–55) | 50 (45–55) |

Modified MMS* | n=10 (13.7%) | n=12 (17.4%) |

Surgical repair technique | ||

Flap repair | n=68 (94.5%) | n=58 (88.4%) |

Skin graft | n=3 (4.1%) | n=6 (8.7%) |

Wedge excision | n=1 (1.4%) | n = 2 (2.9%) |

Median defect size (IQR); range (mm) | 13 (11.5–16); 9–25 | 14 (12–16.5); 9–30 |

*Delayed surgical closure awaiting complete histological margin analysis.

MMS, Mohs micrographic surgery.